More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

President Donald Trump has nominated Kennedy to be the secretary of the U.S. Department of Health and Human Services, which ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

Lively said patients’ primary concerns about prescriptions are cost and convenience/access. The CareArc pharmacy will enable ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...

House Democrats press the Trump administration for clarity on how the president's order rescinding Biden's drug cost ...

The Indiana Capital Chronicle sued the Indiana Department of Correction (IDOC) last week — a move we as an outlet don’t take ...

AbbVie forecast 2025 profit above estimates on Friday, as strong sales of its newer immunology drugs Skyrizi and Rinvoq make up for a steep decline in those of Humira, its flagship rheumatoid ...